By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Viron Therapeutics Inc. 

UWO Research Park
700 Collip Circle, Suite 203
London  Ontario  N6G 4X8  Canada
Phone: 519-858-5109 Fax: 519-858-5103


SEARCH JOBS








Company News
Viron Therapeutics Inc. Reports Positive Proof of Concept Results in Arthritis for its VT-346 Anti-TNF Therapeutic 3/16/2010 8:44:55 AM
Viron Therapeutics Inc. Granted U.S. Patents for Organ Transplant and Arthritis Drug Candidates 12/22/2009 9:02:49 AM
Viron Therapeutics Inc. to Present Data from Phase II Trial at American Heart Association Conference 11/12/2009 8:21:06 AM
Viron Therapeutics Inc. Appoints Claude Benedict, M.D. as New Senior Vice President, Clinical Development and Regulatory Affairs 5/1/2007 1:14:26 PM
Viron Therapeutics Inc. Signs Agreement With Diosynth Biotechnology For Clinical Manufacturing Of VT-111 10/25/2006 10:34:38 AM
Viron Therapeutics Inc. Signs Agreement With Diosynth Biotechnology For Clinical Manufacturing Of VT-111 10/24/2006 11:18:04 AM
Viron Therapeutics Inc.'s VT-111 Among Top 10 Most Promising Drugs 10/4/2006 2:16:20 PM
Viron Therapeutics Raises US $20 Million Series A Financing; Positions Viron To Complete Phase II Trial And Advance Additional Compounds Into Clinical Development 5/16/2006 10:32:43 AM
Viron Therapeutics Wins Prestigious 2005 Prix Galien Award 11/14/2005 11:27:55 AM
Viron Therapeutics Initiates Phase 2 Clinical Trial Of Novel Anti-Inflammatory For Acute Coronary Syndromes10/19/2005 5:12:47 PM
12
//-->